Vianney Tricou
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Mapping immune responses to TAK-003 dengue vaccine: immunogenicity across the clinical development program.
Journal: Frontiers in immunology
Published: April 09, 2026
Beyond neutralization: A comprehensive framework for evaluating humoral immunity induced by a live-attenuated tetravalent dengue vaccine.
Journal: Vaccine
Published: March 18, 2026
Characterization of vaccine viremia, attenuation reversion, and safety: Combined results from the TAK-003 dengue vaccine clinical development program.
Journal: Vaccine
Published: December 19, 2025
Letter to Editor: Rattanaumpawan et al. Severe dengue hemorrhagic fever after TAK-003 dengue vaccination: A case report of a potential vaccine-associated adverse reaction.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: December 12, 2025
Humoral and cellular responses to a tetravalent dengue vaccine (TAK-003) in adults from a dengue non-endemic region: An open-label phase 2 trial.
Journal: Vaccine
Published: December 09, 2025
Comment on: Pettersson et al. Qdenga-induced dengue caused by minor DENV-2 subvariant(s) in the vaccine, with two amino acid substitutions in the E protein.
Journal: Journal of travel medicine
Published: December 05, 2025
TAK-003: development of a tetravalent dengue vaccine.
Journal: Expert review of vaccines
Published: April 10, 2025
Operational challenges and lessons learned from conducting febrile surveillance in a long-term randomized dengue vaccine trial in Latin America and Asia-Pacific.
Journal: Travel medicine and infectious disease
Published: January 14, 2025
Dengue virus infection reprograms baseline innate immune gene expression.
Journal: Med (New York, N.Y.)
Published: October 01, 2024
Estimated Efficacy of TAK-003 Against Asymptomatic Dengue Infection in Children and Adolescents Participating in the DEN-301 Trial in Asia Pacific and Latin America.
Journal: The Journal of infectious diseases
Published: September 17, 2024
Early onset of protection of the TAK-003 dengue vaccine: Data from the DEN-301 clinical trial.
Journal: Vaccine
Published: June 07, 2024
Reply to: Editorial "The increasing use of T-cell stimulation for successful dengue vaccination" in eBioMedicine 2024; 102, 105120. DOI: https://doi.org/10.1016/j.ebiom.2024.105120.
Journal: EBioMedicine
Published: April 30, 2024
Last Updated: 09/26/2026